Mangoceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MGRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
26 Jun 24	SellUS$39,834	Alexander Hamilton	Individual		8,333.34	US$4.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MGRX?
Owner Type	Number of Shares	Ownership Percentage
Institutions	91,338	1.46%
Private Companies	848,334	13.6%
Individual Insiders	1,016,670	16.3%
General Public	4,292,454	68.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 291%.

Top Shareholders

Top 18 shareholders own 31.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.9%	Jacob Cohen	805,000	US$1.6m	33.1%	no data
8.24%	Greenfield Investments Ltd.	515,000	US$1.1m	0%	no data
5.33%	Maab Global Limited	333,334	US$680.0k	0%	no data
0.96%	Tony Isaac	60,000	US$122.4k	0%	no data
0.61%	Eugene Johnston	38,334	US$78.2k	0%	no data
0.59%	Lorraine D’Alessio	36,667	US$74.8k	214%	no data
0.59%	Kenny Myers	36,667	US$74.8k	214%	no data
0.55%	Ackerman Capital Advisors, LLC	34,500	US$70.4k	-40.8%	0.02%
0.45%	Alexander Hamilton	28,334	US$57.8k	1,600%	no data
0.33%	Virtu Financial LLC, Asset Management Arm	20,501	US$41.8k	1,530%	no data
0.22%	Hudson River Trading LLC, Asset Management Arm	13,472	US$27.5k	0%	no data
0.19%	Geode Capital Management, LLC	12,003	US$24.5k	37.1%	no data
0.19%	Amanda Hammer	11,668	US$23.8k	0.01%	no data
0.074%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	4,600	US$9.4k	0%	no data
0.042%	Tower Research Capital Europe Limited	2,633	US$5.4k	0%	no data
0.034%	Steward Partners Investment Advisory, LLC	2,094	US$4.3k	0.05%	no data
0.024%	UBS Asset Management AG	1,524	US$3.1k	0%	no data
0.00018%	Bank of America Corporation, Asset Management Arm	11	US$22.9	10%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/24 15:23
End of Day Share Price	2025/04/24 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mangoceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.